Top Markets
#1 Helium Helium +106.09%
#2 MowCat MowCat +86.97%
#3 Seeker Seeker +55.97%
#4 UnifAI Network UnifAI Network +35.21%
#5 TENDIES TENDIES +28.13%
#6 Zylo Ecosystem Zylo Ecosystem +22.49%
#7 Tensor Tensor +20.12%
#8 Pons Pons +19.98%
#9 pipedog pipedog +19.61%
#10 MarsCoin MarsCoin +16.29%
Coin of the day
Helium Helium
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd.

SENORES
Rang in Aktien #11030
Established in 2017 and headquartered in Ahmedabad, India, Senores... Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
Aktienkurs
$16.36
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$753.27M
Veränderung (1 Tag)
0.51%
Veränderung (1 Jahr)
108.95%
Land
IN
Handel Senores Pharmaceuticals Ltd. (SENORES)

Kategorie

Healthcare
P/B-Verhältnis für Senores Pharmaceuticals Ltd. (SENORES)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Senores Pharmaceuticals Ltd. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Senores Pharmaceuticals Ltd. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 31.0864 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.4766 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -74.4354 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.008 -
US